NICE uses wrong comparator to assess cost effectiveness of new drugs, report says

被引：0
|
作者：
Hawkes, Nigel
机构：
来源：
BMJ-BRITISH MEDICAL JOURNAL | 2014年 / 348卷
关键词：
D O I：
10.1136/bmj.g2134
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Assessment of the clinical and cost-effectiveness evidence in the reimbursement decisions of new cancer drugs
    Strand, G. Chauca
    Bonander, C.
    Jakobsson, N.
    Johansson, N.
    Svensson, M.
    ESMO OPEN, 2022, 7 (05)
  • [32] Acceptable Incremental Cost Effectiveness Ratio for Use of New Drugs, Cases in Statin Therapies
    Nakao, Susumu
    Kawabe, Hiroyuki
    Takuma, Hiroki
    Shiragami, Makoto
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2010, 130 (10): : 1347 - 1352
  • [33] NEW DRUGS AND CLINICAL ECONOMICS - ANALYSIS OF COST-EFFECTIVENESS IN THE ASSESSMENT OF PHARMACEUTICAL INNOVATIONS
    EISENBERG, JM
    REVIEWS OF INFECTIOUS DISEASES, 1984, 6 : S905 - S908
  • [34] Changing environments and alternative perspectives in evaluating the cost-effectiveness of new antipsychotic drugs
    Rosenheck, R
    Doyle, J
    Leslie, D
    Fontana, A
    SCHIZOPHRENIA BULLETIN, 2003, 29 (01) : 81 - 93
  • [35] MULTI-COMPARATOR ICERS IN COST-EFFECTIVENESS ANALYSIS TO ACCOUNT FOR CHANGES IN CLINICAL PRACTICE AFTER THE INTRODUCTION OF A NEW TECHNOLOGY
    Hughes, R.
    Lucherini, S.
    Crossley, A.
    Okhuoya, P.
    VALUE IN HEALTH, 2018, 21 : S376 - S376
  • [36] Cancer treatment in Sweden - costs of drugs, inpatient and outpatient care from 1985 to 1996 and cost effectiveness of new drugs
    Acta Oncol, 5 (447-453):
  • [37] Cancer treatment in Sweden - Costs of drugs, inpatient and outpatient care from 1985 to 1996 and cost effectiveness of new drugs
    Tennvall, GR
    Karlsson, G
    ACTA ONCOLOGICA, 1998, 37 (05) : 447 - 453
  • [38] MULTI-COMPARATOR ICERS IN COST-EFFECTIVENESS ANALYSIS TO ACCOUNT FOR CHANGES IN CLINICAL PRACTICE AFTER THE INTRODUCTION OF A NEW TECHNOLOGY
    Weston, G.
    Hughes, R.
    Mountain, G.
    VALUE IN HEALTH, 2023, 26 (12) : S111 - S111
  • [39] AN ECONOMIC EVALUATION TO ASSESS THE COST EFFECTIVENESS OF THE NEW MEDICINE SERVICE IN IMPROVING ADHERENCE IN PEOPLE INITIATED ON NEW TREATMENT FOR GOUT
    Brinkmann, L.
    Elliott, R.
    Tanajewski, L.
    VALUE IN HEALTH, 2015, 18 (07) : A650 - A650
  • [40] A global economic model to assess the cost-effectiveness of new treatments for advanced breast cancer in Canada
    Beauchemin, C.
    Letarte, N.
    Mathurin, K.
    Yelle, L.
    Lachaine, J.
    JOURNAL OF MEDICAL ECONOMICS, 2016, 19 (06) : 619 - 629
12345